Sam Brusco, Associate Editor01.06.22
Stryker announced an agreement to acquire Vocera Communications for $79.25 per share, valuing the deal at about $2.97 billion with an enterprise value of about $3.09 billion. Vocera was founded in 2000 and features a digital care coordination and communication platform. This segment in particular is expected to grow throughout the pandemic because it aims to minimize caregivers’ cognitive overload.
The portfolio complements Stryker’s Medical division by addressing the need for hospitals to connect caregivers and disparate, data-generating medical devices. Vocera’s software competency, hardware solutions, and secure remote communication between patients and families complements Stryker’s Advanced Digital Healthcare products.
“This acquisition underscores our commitment and focus on our customer," Kevin Lobo, Stryker’s Chair and CEO told the press. “Vocera will help Stryker significantly accelerate our digital aspirations to improve the lives of caregivers and patients.”
“[This] milestone represents an exciting opportunity for Vocera given the clear alignment of mission, goals and culture between our two organizations and our ability to drive even greater economic and clinical value for our customers,” said Brent Lang, Chairman and CEO of Vocera.
The boards of directors of both companies have unanimously approved the deal, which is expected to close in the first quarter of this year.
The portfolio complements Stryker’s Medical division by addressing the need for hospitals to connect caregivers and disparate, data-generating medical devices. Vocera’s software competency, hardware solutions, and secure remote communication between patients and families complements Stryker’s Advanced Digital Healthcare products.
“This acquisition underscores our commitment and focus on our customer," Kevin Lobo, Stryker’s Chair and CEO told the press. “Vocera will help Stryker significantly accelerate our digital aspirations to improve the lives of caregivers and patients.”
“[This] milestone represents an exciting opportunity for Vocera given the clear alignment of mission, goals and culture between our two organizations and our ability to drive even greater economic and clinical value for our customers,” said Brent Lang, Chairman and CEO of Vocera.
The boards of directors of both companies have unanimously approved the deal, which is expected to close in the first quarter of this year.